Search for European Projects

17 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project. (TackSHS)

Start date: Nov 1, 2015, End date: Oct 31, 2019,

"Exposure to secondhand tobacco smoke (SHS) has been classified as a "Group 1" carcinogen (known human carcinogen) by the International Agency for Research on Cancer and has been shown to have adverse health effects on adults and children, including heart disease and respiratory disorders. Electronic cigarettes (e-cigarettes), the most common “electronic nicotine delivery system”, have irrupted i ...
Read Project

 11

 FINISHED 

Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) (MoTriColor)

Start date: Oct 1, 2015, End date: Sep 30, 2019,

Colorectal cancer (CRC) is increasingly being recognized as a heterogeneous disease with distinct molecular subtypes. These subtypes have different biological processes at the basis of their disease and consequently their prognosis and responses to therapy are also different.We have previously developed molecular diagnostic assays using a single platform on routine FFPE tumour biopsies. These assa ...
Read Project

 12

 FINISHED 

European Regulatory Science on Tobacco:Policy implementation to reduce lung diseases (EUREST-PLUS)

Start date: Jan 1, 2016, End date: Dec 31, 2018,

Smoking and other forms of tobacco consumption are considered the single most important cause of preventable morbidity and premature mortality worldwide. Efforts to reduce the devastation of tobacco-related deaths and illness in the EU consist of the Tobacco Products Directive (TPD), and the ongoing implementation of the WHO Framework Convention on Tobacco Control (FCTC). The main objective of EUR ...
Read Project

 13

 FINISHED 

Comparing health services interventions for the prevention of HPV-related cancer (COHEAHR)

Start date: Nov 1, 2013, End date: Oct 31, 2018,

Important progress has been made in the field of HPV-disease prevention with the development and implementation of HPV vaccines and HPV DNA screening. In the CoheaHr project, the (cost-) effectiveness of different European preventive strategies will be compared. The goal is to build a reliable and comparable evidence base on the (cost-) effectiveness of these policies implemented under country-spe ...
Read Project

 13

 FINISHED 

Coordinated Development of Inhibitors and Biomarkers for Resistance to Antiangiogenics in Cancer - AngioResist (AngioResist)

Start date: Sep 1, 2016, End date: Feb 28, 2018,

Many anti-angiogenic drugs are clinically used in several types of cancer to block angiogenesis, impair tumor growth, progression and dissemination. Nevertheless, clinical trials report emergence of resistance to treatment and a failure in long-lasting effects of these therapies. To date, resistant patients do not currently have any established, proven alternative therapeutic possibility and the m ...
Read Project

 1

 FINISHED 

Identification of new colorectal cancer susceptibility genes (Finding CRC genes)

Start date: Jun 17, 2013, End date: Jul 6, 2017,

The overall aim of this proposed project is to discovery new colorectal cancer (CRC) susceptibility genes to better understand the colorectal carcinogenesis process and improve the molecular diagnosis the affected families.CRC is one of the most important causes of morbidity and mortality in occidental countries. An early diagnosis of CRC as well as clinical surveillance of those with an increased ...
Read Project

 1

 FINISHED 

Mechanisms and Targeting Stromal Contribution to Tumour Invasion and Metastasis (STROMALIGN)

Start date: Jun 1, 2012, End date: May 31, 2017,

"Angiogenesis inhibition has proven to be a successful anti-cancer therapeutic approach and anti-angiogenic therapies are currently approved as standard therapy in several types of cancer for their clinically validated beneficial extension of overall survival, progression-free survival and/or time-to-progression in these cancer patients. Nevertheless, in preclinical mouse models of cancer, althoug ...
Read Project

 1

 FINISHED 

Use of adoptive T cell transfer in combination with oncolytic adenoviruses for cancer treatment (Cancer therapies)

Start date: May 1, 2011, End date: Aug 31, 2015,

Metastatic cancer remains an incurable disease in the majority of cases and thus development of novel treatment strategies is required. Adoptive T cell therapy is a promising therapy for patients with a wide range of cancers. This therapy involves ex vivo activation and expansion of T cells followed by infusion into patients. Peripheral blood CD4+ and CD8+ T cells can be redirected against tumor-a ...
Read Project

 2

 FINISHED 

Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe (HPV-AHEAD)

Start date: Sep 1, 2011, End date: Aug 31, 2015,

Human papillomavirus (HPV) is responsible for approximately 25% of head and neck cancer (HNC) worldwide and appears to be associated with a better response to treatment and improved prognosis. Evidence suggests that HPV-induced HNC has steadily increased in the USA and some European countries in the last decades. However, whether this is a worldwide phenomenon and specific risk factors are associa ...
Read Project

 11

 FINISHED 

European Stroke Research Network (EUSTROKE)

Start date: Mar 1, 2008, End date: Aug 31, 2013,

The European Stroke Research Network (EUSTROKE) will be a collaborative effort that brings together researchers, government, industry, the non-profit sector and patient group associations. This network will put Europe at the forefront of stroke research through its multi-disciplinary research program, high-quality training for European scientists and clinicians, and national and global partnership ...
Read Project

 17

 FINISHED 

health-economic modelling of PREvention strategies for Hpv-related Diseases in European CounTries (PREHDICT)

Start date: May 1, 2010, End date: Apr 30, 2013,

"The goals of the PREHDICT study are to determine prerequisites and strategies for vaccination in European countries and to predict the impact of vaccination on screening programmes. To achieve these goals, a multiple HPV type transmission model will be built to describe the type-specific incidence and clearance of HPV infections. This model will be linked to an individual-based simulation model u ...
Read Project

 14

 FINISHED 

Development of High Performance Diagnostic Array Replication Technology (HiPerDART)

Start date: Jan 1, 2009, End date: Dec 31, 2012,

Development of High Performance Diagnostic Array Replication Technology (HiPerDART) As with any new technology, the use of DNA microarrays has presented a number of important obstacles, many of which have limited their ability to move beyond research applications. For example, the data obtained from a traditional microarray experiment can fluctuate dramatically due to small perturbations in assay ...
Read Project

 7

 FINISHED 

Metagenomics of the Human Intestinal Tract (MetaHIT)

Start date: Jan 1, 2008, End date: Jun 30, 2012,

A detailed understanding of human biology will require not only knowledge of the human genome but also of the human metagenome, defined here as the ensemble of the genomes of human-associated microorganisms. Our proposal focuses on the microorganisms of the gut, which are particularly abundant and complex and have an important role for human health and well-being. We shall implement and integrate ...
Read Project

 16

 FINISHED 

Pricing Policies and Control of Tobacco in Europe (PPACTE)

Start date: Feb 1, 2009, End date: Apr 30, 2012,

"Price is the single most important intervention in tobacco control (TC). To protect the health of its citizens the EU now has a major role in regulating tobacco fiscal policy (FP) through a number of EU directives. The aims of these directives initially were to ensure the proper functioning of the internal market. The directives aided harmonization in EU Member States (MS) but now with EU enlarge ...
Read Project

 8

 FINISHED 

iNTER Support Action (International Network of Teleconsultation Excellence & Referral) (iSA)

Start date: Sep 1, 2009, End date: Feb 29, 2012,

The iNTER Support Action (iSA) Project aims to create a pilot cooperative medical support network constituted by the Hospital Son Espases (former Son Dureta) (Spain), the Instituto Valenciano de Oncología (Spain), the Hospital Vall d’Hebron (Spain), the Hospital Sant Joan de Déu (Spain), the Hospital Regional de Bata (Equatorial Guinea), the Desarrollo 2000 en África NGO (Equatorial Guinea), the H ...
Read Project

 11

 FINISHED 

Characterization of the role of histone H1 and its post-translational modifications in the functional regulation of chromatin (HISTONE H1 FUNCTION)

Start date: Oct 1, 2007, End date: Sep 30, 2009,

Histone H1 participates in both the establishment and stabilization of high-order of chromatin organization through its binding to the internucleosomal DNA. H1 seems to play an important role in regulation of chromatin functions, and particularly in the regulation of gene expression and chromosome condensation.However, our understanding of H1 function is based mainly on in vitro studies and we do ...
Read Project

 1

 FINISHED 

Supporting innovative learning approaches through Mobile Integration in the workpLacE - Oncology Nursing

Start date: Nov 1, 2011,

This project will develop a new approach to vocational training using mobile devices to extend learning activity into daily practice so that theory is fully integrated with practical skills development. It will be developed in the context of oncology nursing. Using smart phones, nurses will be able to communicate with each other and their tutors in real time in the work place and access relevant c ...
Read Project

 7